Enzepi, INN-pancreas powder - Chirurgie
|
Longer product no
Enzepi is a medicine used to treat adults and children no whose pancreas does not produce enough enzymes (a condition known as pancreatic insufficiency) due to cystic fibrosis or other conditions such as pancreatic cancer Pancreas enzymes are needed to digest fats carbohydrates and proteins |
|
Enzepi INN-pancreas powder
Enzepi INN-pancreas powder I PIELIKUMS ZĀĻU APRAKSTS Enzepi 5 000 vienības zarnās šķīstošās cietās kapsulas Enzepi 10 000 vienības zarnās šķīstošās cietās kapsulas Enzepi 25 000 vienības zarnās šķīstošās cietās kapsulas Enzepi 40 000 vienības zarnās šķīstošās cietās kapsulas 2 KVALITATĪVAIS UN KVANTITATĪVAIS SASTĀVS |
|
Enzepi INN-pancreas powder
Exocrine pancreatic insufficiency (EPI) is a condition in which the exocrine function of the pancreas is compromised and its ability to effectively deliver digestive enzymes to the duodenum is impaired It is a serious health condition that leads to malabsorption of lipids fat-soluble vitamins proteins and to a lesser |
|
Enzepi INN-pancreas powder
Enzepi 5000 units gastro-resistant hard capsules One capsule contains 39 8 mg of pancreas powder of porcine origin including the following enzymatic activities: lipolytic activity: 5000 units* amylolytic activity: not less than 1600 units* proteolytic activity: not less than 130 units* Enzepi 10000 units gastro-resistant hard capsules |
Does enzepi cause blood glucose fluctuations?
Cases of blood glucose fluctuations have been reported with Enzepi, most of them non-serious and recovered after diabetic treatment adjustment. The most relevant class effects of the pancreatic enzyme products include fibrosing colonopathy, hyperuricaemia/ hyperuricosuria and anaphylactic reactions.
How many enzymatic units are in enzepi?
2. Enzepi 5,000 units gastro-resistant hard capsules One capsule contains 39.8 mg of pancreas powder of porcine origin including the following enzymatic activities: lipolytic activity: 5,000 units*, amylolytic activity: not less than 1,600 units*, proteolytic activity: not less than 130 units*. 10,000 units*, 3,200 units*, 270 units*.
What is enzepi used for?
See section 4. Enzepi is a pancreatic enzyme replacement medicine for people whose bodies do not make enough of enzymes to digest food. Enzepi contains a mixture of natural digestive enzymes which are used to digest food. These include lipases for digesting fat, proteases for digesting protein and amylases for digestions carbohydrates.
What is pancreatic enzyme replacement treatment?
Pancreatic enzyme replacement treatment in exocrine pancreatic insufficiency due to cystic fibrosis or other conditions (e.g. chronic pancreatitis, post pancreatectomy or pancreatic cancer). Enzepi is indicated in infants, children, adolescents and adults.
